Older patients with stable ischemic heart disease (SIHD) who undergo complex PCI are at higher risk of all-cause death by 1 year than are those who undergo noncomplex PCI, according to new ...

Data from the ORBITA-2 randomized, placebo-controlled trial emphasize that patient age alone should not be the deciding ...

Please provide your email address to receive an email when new articles are posted on . P2Y12 monotherapy after PCI was not as protective from ischemic events vs. DAPT with aspirin. Monotherapy did ...

In patients undergoing PCI, anemia increased bleeding risk regardless of CKD status, whereas CKD by itself did not. Anemia increases the risk of bleeding in patients who have undergone percutaneous ...

The beneficial effect of clopidogrel monotherapy over aspirin monotherapy in patients who underwent percutaneous coronary intervention (PCI) and remained event free for 6-18 months on dual ...

People with a buildup of fatty atherosclerotic plaque in the heart's arteries considered at risk of rupturing were far less likely to suffer a serious cardiac event if they underwent percutaneous ...

Among secondary-prevention patients who are event free for 6 to 18 months after PCI, clopidogrel seems to be superior to aspirin monotherapy over the next 2 years regardless of the patient’s baseline ...

Design by Evelyn Mousigian. Buy this photo. Researchers at Michigan Medicine have created an artificial intelligence-powered algorithm to help predict the various risk factors that come with ...

Please provide your email address to receive an email when new articles are posted on . Registry data show transradial access was used for most patients who underwent complex, high-risk PCI.

Compared with high-intensity statin therapy, moderate intensity statin therapy plus ezetimibe was equally effective in preventing CV events among patients undergoing PCI. Moderate-intensity statin ...